2022-2088 is the forecast period in the market report.
The drug test primarily analyses biological samples, including blood, hair, and urine; diagnose the presence of drug addiction or its metabolites in the patient's body. Tests are designed to determine if a person is or was under the influence of drugs at any given time. Thanks to the introduction of new technologies, users get precise and accurate results. The increase in alcohol consumption among young and old, the excessive use of prescription drugs, and the increase in the consumption of narcotics and illicit drugs are some of the key important drivers for the market. In order to decrease the consumption of addictive drugs, strict regulations are widely imposed all over the world. Due to these factors, the market is expected to grow tremendously over the forecast period.
Drug abuse and alcohol consumption are increasing worldwide. According to the World Drug Report 2021, an estimated 275 million people aged 15-64, or 1 in 18 people in that age group, have used drugs at least once in the past year, and also, approximately 36.3 million people, or nearly 13% of the world's population, suffer from drug use disorders. In the same year, nearly half a million people died from drug use, while drug use disorders claimed 18 million years of healthy life, mostly due to opioids. Alcohol consumption has also increased, leading to an increase in the number of people with disabilities. Increased consumption of illicit drugs and alcohol will further stimulate the development of drug screening products and services. This is expected to fuel overall market growth during the estimated time period. The enforcement by several government agencies of strict laws requiring drug testing for safety reasons has fuelled the demand for innovative products. This is expected to drive the growth of the market to a significant extent over the forecast period.
Fingerprint-based drug testing is a relatively new concept that has gained importance due to the COVID-19 pandemic. The coronavirus has made it difficult to conduct drug testing in hospitals, laboratories, and other facilities due to the risk of transmitting the infection. While fingerprint-based drug screening can help limit the spread of COVID, it is non-invasive, portable, less time-consuming, hygienic, socially distinguishable, easy to use, and requires no special preparation for specimen collection and handling. This test is very easy to implement where and when needed, allowing for flexible and effective drug testing in the workplace. The test analyses tiny traces of sweat in the fingerprint to detect drugs and drug metabolites. This test is used in employment, criminal justice, law enforcement, and drug rehabilitation programs. The test analyses tiny traces of sweat in the fingerprint to detect drugs and drug metabolites. If widely adopted, this test is anticipated to replace drug tests based on urine, hair, and blood. This factor is expected to provide increasing new growth opportunities for the market over the forecast period.
The right to privacy and the ban on drug and alcohol testing in several countries are likely to be major factors hindering market growth. Many European countries impose fines for unjustified testing, with criminal penalties as well. This is considered an invasion of employee privacy. Therefore, such strict privacy rights are likely to limit workplace testing. This is a key factor which is expected to restrain market growth over the forecast period.
Bans and prohibitions on alcohol consumption in many Islamic countries and a lack of healthcare infrastructure in developing countries are expected to hamper the growth of the global drug testing market during the forecast period. Also, a lack of a skilled work force in the healthcare sector in underdeveloped nations is expected to be a major challenge for the market’s growth over the forecast period.
The report provides an in-depth analysis of the global Drug Testing market, market size, and compound annual growth rate (CAGR) for the forecast period of 2022-2028, considering 2021 as the base year. The increasing demand for various Drug Testing services in various substance and drug abuse applications has led to the increasing demand for the market and is expected to witness growth at a specific CAGR from 2021-2028.
The Global Drug Testing market comprises of different market segments like products and services, sample type, drug type, end users and geography.
The key segment of the Drug Testing Market includes
Consumables are further sub-segmented into assay kits, sample collection cups, calibrators and controls, and other consumables. Instruments are further sub-segmented into immunoassay analyzers, chromatography instruments, and breath analyzers. Breath analyzers is further sub-segmented into fuel cell analyzers and semiconductor breath analyzers. Rapid testing devices are further sub segmented into urine testing devices and oral fluid testing devices.
The consumables segment is expected to dominate the market over the forecast period. The increasing introduction of advanced consumables that provide improved solutions to make testing simple, accurate, and fast is expected to accelerate the growth of the segment. The calibrators and controls sub-segment is expected to grow at a high rate over the forecast period. Calibrators and controls perform confirmation tests for laboratories to eliminate measurement steps and manage controls and certifications, purchase and set up materials, and multiple operations.
The laboratory services segment is anticipated to witness significantly high growth over the forecast period. An increase in strategic initiatives by various companies, such as acquisitions, collaborations, and partnerships in support of public safety and government agencies, is expected to fuel the growth of the segment.
By sample type, the Drug Testing market is segmented into
The urine samples segment is expected to grow faster over the forecast period. This high growth can be attributed to the fact that urine samples are the most commonly used type of sample to detect the presence of illegal substances. However, counterfeiting is increasingly common in urine samples to produce a false negative result, which could negatively affect market growth.
On the other hand, the oral fluid sample segment is expected to witness a significant growth rate over the forecast period as it is a faster and less invasive sample to collect along the way. According to an NCBI 2020 study, a survey by both staff and patients concluded that oral fluid samples are preferred over urine samples because they save time and maintain dignity regardless of the additional cost.
By drug type, the Drug Testing market is segmented into
The cannabis / marijuana segment is expected to dominate the drug testing market over the forecast period. This can be attributed to the fact that marijuana or cannabis is the most widely used illicit drug in key markets, creating a big demand for its test kits and tools. According to the Substance Abuse and Mental Health Services Administration, marijuana was the most commonly used illicit drug in the United States in 2018, used by approximately 43.5 million people.
The opioid segment is anticipated to have the second largest revenue share over the projection period. This high share can be attributed to the increase in opioid crises in key markets, including North America, and the introduction of innovative opioid testing solutions.
The Drug Testing market has major end users like
Drug testing labs are anticipated to dominate the market over the forecast period. This is due to their wide acceptance due to their accurate results. Drug testing labs can test for any illegal substance, unlike rapid tests. Other advantages of drug testing labs include the availability of sophisticated equipment such as HPLC and spectroscopy, and trained staff to perform tests for effective results. Therefore, laboratories provide test results with greater sensitivity and specificity compared to rapid tests. Workplaces are expected to be the fastest growing segment over the forecast period as pre-employment drug screening and random drug testing to ensure drug-free premises are increasingly used. In addition, in the case of accidents at work, drug tests can be used to determine whether the accident occurred under the influence of drugs, which releases the employer from any responsibility in the event of damage.
The global Drug Testing market is studied for the following regions
The North America region is expected to remain the leader throughout the forecast period. The presence of prominent players implementing large-scale expansion strategies and stringent workplace testing regulations are some of the major factors contributing to the region's market share. Favourable repayment scenarios and strong acceptance of technologically advanced solutions in the region have also supported the market’s growth.
In Asia-Pacific, the market is expected to witness lucrative growth over the forecast period owing to the rising demand for drug addiction screening from emerging markets like China and India. The increasing prevalence of substance use disorders, drug offenses and fatal traffic accidents has increased the demand for drug testing in these countries.
Axiom MRC conducts a comprehensive 360-degree analysis of micro and macro-economic factors affecting the global Drug Testing market. Also, a complete analysis of changes in the global Drug Testing market expenditure, economic and international policies on the supply and demand side is provided in this exclusive report. The report also studies the impact of the pandemic on global economies, international trade, business investments, GDP, and marketing strategies of key players present in the market.
COVID-19 has caused significant disruptions to businesses and economic activities around the world and is expected to negatively impact the drug screening market in the short term due to the limited or unavailability of medical facilities and care centers, suppliers harm reduction services, and infection transmission concerns. To ease the pressure on the healthcare system and reduce disease transmission, several governments around the world have issued guidelines to delay or delay nonessential medical and surgical procedures. Restrictions and blocks were also imposed on travel, commercial activities, public gatherings, and on-site orders, which further influenced market growth. Several countries around the world that have announced nationwide closures or temporary closures of industries, manufacturing, and business development have been hit hard. Trade barriers further negatively impact the gap between supply and demand. Companies operating in the drug screening market have seen disruptions in the global supply chain, reduced demand or suspension of operations by their customers.
The competitive landscape analysis of Drug Testing market is majorly focused on expanding the global growth of Drug Testing with new product innovation, business expansion, and the increasing presence of key players operating in Drug Testing industry has led the growing demand for the market. Besides, the market offers a range of testing services in different applications to fulfil the consumer which is further contributing to healthy growth in the market.
The key players studied in market are
August 2021: Quest Diagnostics and Select Health of South Carolina had entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees and to enhance access to diagnostics information services for members.
September 2020: LabCorp entered into a multi-year agreement with Infirmary Health to offer laboratory testing services in the US.
By products and services, the Drug Testing market includes the key segments of consumables, instruments, rapid testing devices, and laboratory services. Consumables are further sub-segmented into assay kits, sample collection cups, calibrators and controls, and other consumables. Instruments are further sub-segmented into immunoassay analyzers, chromatography instruments, and breath analyzers. Breath analyzers is further sub segmented into fuel cell analyzers and semiconductor breath analyzers. Rapid testing devices are further sub-segmented into urine testing devices and oral fluid testing devices. The consumables segment is expected to dominate the market over the forecast period. By sample type, the Drug Testing market is segmented into urine samples, breath samples, oral fluid samples, hair samples, and other samples. The urine samples segment is expected to grow faster over the forecast period. By drug type, the drug testing market is segmented into alcohol, cocaine, opioids, amphetamine, methamphetamine, cannabis, marijuana, LSD, and others. The cannabis, marijuana segment is expected to dominate the drug testing market over the forecast period. The Drug Testing market has major end users like drug testing laboratories, workplaces, hospitals, drug treatment centers, individual users, criminal justice systems and law enforcement agencies, pain management centers, schools, colleges, and others. Drug testing labs are anticipated to dominate the market over the forecast period. The global Drug Testing market is studied for the following regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North America region is expected to remain the leader throughout the forecast period.
|Market Sizing for Year:
|Market Segment studied:
Products and Services
|Market Players and Its
Thermo Fisher Scientific,
Biorad Laboratories, Inc.
Hoffmann-La Roche AG
Agilent Technologies, Inc.
American Bio Medica
CareHealth America Corp
Omega Laboratories, Inc.
Premier Biotech, Inc.
What would be forecast period in the market report?
2022-2088 is the forecast period in the market report.
What are the drivers for Drug Testing market?
The key driving factors of the market are increasing incidences of substance abuse and increase in governmental funding to control drug trafficking.
Which region is gaining majority of market share during the forecast period (2022-2028)?
North America is expected to gain major market share during the forecast period (2022-2028).